Gene · 92521
NIH grants1,071
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,071
Download this page as JSON| Grant | Title | SPECC1 papers | Newest fiscal year |
|---|---|---|---|
| U01DK085527 | Investigation and Translation of the Intestinal Stem Cell Niche | 1 | 2023 |
| U01MH116492 | 1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders | 1 | 2023 |
| U19AI111825 | Integrating innate and adaptive pathways in vaccine responses | 1 | 2023 |
| U19AI142762 | Center of Excellence for Encephalitic Alphavirus Therapeutics | 1 | 2023 |
| U19AI144184 | Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis | 1 | 2023 |
| U19AI171413 | UTMB-Novartis Alliance for Pandemic Preparedness | 1 | 2023 |
| U24CA224370 | Knowledge Management Center for Illuminating the Druggable Genome | 1 | 2023 |
| U24TR002278 | Illuminating the Druggable Genome Resource Dissemination and Outreach Center (IDG-RDOC) | 1 | 2023 |
| UL1TR001414 | Institute for Clinical and Translational Science | 1 | 2023 |
| UL1TR001422 | Northwestern University Clinical and Translational Science Institute (NUCATS) | 1 | 2023 |
| ZIAAI001088 | Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens | 1 | 2023 |
| ZIAAI001288 | SARS-CoV-2 pathogenesis and countermeasures | 1 | 2023 |
| ZIABC011969 | Development of Cell-based Assays to Identify SARS-CoV-2 Protease Inhibitor | 1 | 2023 |
| ZIATR000457 | COVID-19: Assay Development, HTS and Drug Repurposing to identify potential therapeutics against SARS-CoV-2 | 1 | 2023 |
| R01AI147325 | High Throughput Screening of Inhibitors Targeting the Enterovirus A71 and D68 2A proteases | 6 | 2022 |
| R37AI036040 | Structural Studies of Rotaviruses | 6 | 2022 |
| R01AI108197 | Determinants of Coronavirus Fidelity in Replication and Pathogenesis | 4 | 2022 |
| U19AI171954 | Midwest AViDD Center | 4 | 2022 |
| I01BX000158 | Rotavirus: Studies of the Effectors and Mechanisms of Heterotypic Humoral Immunity in Human Intestinal Epithelial Cells | 3 | 2022 |
| R01AI030048 | T cell Memory to Viruses | 3 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/grants?page=23